Warren Woessner is a registered patent attorney and a founding shareholder of Schwegman, Lundberg & Woessner. His practice focuses on chemical patent law, including biotechnology, pharmaceuticals, vaccines, medical treatments, diagnostics, and biofuels and agricultural chemistry, including related opinion and licensing matters.
Warren received his B.A. in chemistry (1966) from Cornell University, his Ph.D. (organic chemistry, 1971) and his law degree (J.D., cum laude, 1981) from the University of Wisconsin – Madison. From 1972-1978 he worked for Miles Laboratories in new drug research. Warren was an associate attorney at Kenyon & Kenyon from 1981-1984, and then joined Merchant & Gould in Minneapolis. He founded their chemical practice group and became a partner in 1989. Warren also co-founded the Biotechnology Committee of the Minnesota Intellectual Property Law Association. He has published and spoken widely on legal topics, was the 1993-1995 chair of the Chemical Practice Committee of the American Intellectual Property Law Association, chaired the Biotechnology Committee (2003-2005) and has served as a member of the Amicus Committee. He co-authored the AIPLA amicus briefs to the Federal Circuit and the Supreme Court in J.E.M. Ag Supply v. Pioneer Hi-Bred. Warren is a Certified Licensing Professional
More Legal and Business Bylines From Warren Woessner
- USTPO Releases Proposed Revised Section 101 Eligibility Guidelines - (Posted On Tuesday, January 08, 2019)
- Top Ten List of Patent News Stories in 2018 - (Posted On Monday, December 31, 2018)
- Legal Wiggle Room in the Joint AIPLA-IPO Proposal on Patentability? - (Posted On Tuesday, December 11, 2018)
- Life Science Patenting to Iancu – “We need help too!” - (Posted On Monday, December 03, 2018)
- Kumar v. Iancu – The Dangers of an Overstuffed Preamble/Note on 37 CFR Part 4. - (Posted On Friday, November 09, 2018)
- Yeda Res. and Dev. v. Mylan – “We don’t need no Stinkin’ Prior Art” - (Posted On Friday, October 19, 2018)
- UCB, Inc. v. Accord Healthcare, Inc. – Can a Racemic Mixture be a “Lead Compound.” - (Posted On Tuesday, October 16, 2018)
- Philips Standard of Claim Construction to be Used by PTAB in “AIA Proceedings” - (Posted On Thursday, October 11, 2018)
- Roche Molecular Systems, Inc. v. Cepheid – Are Primers “Natural Products”? - (Posted On Wednesday, October 10, 2018)
- “Big Data” Claims Meet Mayo/Alice Rule - (Posted On Monday, September 24, 2018)
The National Law Review has awarded Warren Woesssner, shareholder at Schwegman, Lundberg & Woessner, P.A., a Go-To Thought Leadership Award for Mr. Woessner’s ongoing coverage and analysis of patent disputes, updates to USPTO processes and interviews and profiles of prominent federal agency appointees. He provides NLR's readers with a well-rounded view of issues impacting patent law in the U.S. The cases of Yu v. Apple and CareDx v. Natera are especially notable, detailing the complicated intersections between intellectual property, technology, and health law.
Warren Woessner and his thought leadership on Life Sciences Intellectual Property has been selected for a National Law Review Go-To Thought Leadership Award. Mr. Woessner’s coverage of patent litigation, the Patent Trial and Appeals Board and the Court of Appeals for the Federal Circuit and how those decisions fit into the larger landscape of patent litigation is an invaluable resource for NLR readers. You can subscribe to his Patents 4 Life blog here.